ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,283.36
-1.01%
Dow Jones
40,347.97
-1.21%
Gold vs US Dollar
2,443.04
-0.11%
Brent Oil
80.035
-1.81%
Bitcoin
64,583.59
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
01/08/202421:57PR Newswire (US)GATORADE, MIAMI DOLPHINS AND TUA TAGOVAILOA CHAMPION YOUTH ACADEMICS AND ATHLETICS FOR MIAMI STUDENTS THROUGH 'GET FIT FOR SCHOOL' PROGRAMNASDAQ:PEPPepsiCo Inc
01/08/202421:55PR Newswire (US)Total Resource Management, Inc. Partners with 424 Capital to Accelerate Growth and Expand Service Offerings
01/08/202421:55PR Newswire (US)FS Credit Opportunities Corp. (FSCO) Declares Distribution for August 2024NYSE:FSCOFs Credit Opportunities Corp
01/08/202421:54Alliance NewsAlliance NewsTOP NEWS: Apple third quarter sales nudge past expectationsLSE:0R2VApple Inc
01/08/202421:52PR Newswire (US)Batteries Plus Teams Up with Green Bay Packers to Launch Battery Recycling Initiative Backed By U.S. Department of Energy
01/08/202421:47PR Newswire (US)Prepared Unveils New Two-Way Audio Translation to Save Valuable Time on Non-English 911 Calls
01/08/202421:45PR Newswire (US)Second Chance University's Latest Podcast Series, A Mother's Voice, Now Available on Securus Tablets
01/08/202421:45PR Newswire (US)AmpUp Appoints Michael DiNucci as Chief Revenue Officer
01/08/202421:44PR Newswire (US)Sandstorm Gold Royalties Announces 2024 Second Quarter ResultsNYSE:SANDSandstorm Gold Ltd
01/08/202421:44PR Newswire (US)Cooper Standard Second Quarter Gross Profit Ramps Higher; Further Margin Expansion Expected in Second Half of the YearNYSE:CPSCooper Standard Holdings Inc
01/08/202421:44PR Newswire (US)Sandstorm Gold Royalties Announces 2024 Second Quarter ResultsTSX:SSLSandstorm Gold Ltd
01/08/202421:43PR Newswire (US)Curbio Lands Spot on Inc. Magazine's Prestigious Inc. 5000 Regionals: Mid-Atlantic List
01/08/202421:42PR Newswire (US)CON EDISON REPORTS 2024 SECOND QUARTER EARNINGSNYSE:EDConsolidated Edison Inc
01/08/202421:37PR Newswire (US)MasTec Announces Second Quarter 2024 Financial Results and Updates Guidance for the YearNYSE:MTZMasTec Inc
01/08/202421:35PR Newswire (US)AES Reports Record Sales with Data Center HyperscalersNYSE:AESAES Corp
01/08/202421:33PR Newswire (US)Fairwater, the Newest Jones Act Energy and Chemical Transportation Provider, Formally Launches
01/08/202421:30UK RegulatoryLa FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLATG:ZVACellectis Nom Eo 05
01/08/202421:30UK RegulatoryFDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL TreatmentEU:ALCLSCellectis Nom Eo 05
01/08/202421:30UK RegulatoryLa FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLAEU:ALCLSCellectis Nom Eo 05
01/08/202421:30UK RegulatoryFDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL TreatmentTG:ZVACellectis Nom Eo 05
01/08/202421:30PR Newswire (US)Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per ShareNASDAQ:SHBIShore Bancshares Inc
01/08/202421:30PR Newswire (US)Xenia Hotels & Resorts Reports Second Quarter 2024 ResultsNYSE:XHRXenia Hotels and Resorts Inc
01/08/202421:30PR Newswire (US)Ameren Announces Second Quarter 2024 ResultsNYSE:AEEAmeren Corp
01/08/202421:30PR Newswire (US)Inman Celebrates with the Real Estate Community by Announcing the Winners of the 2024 Inman Innovator Awards and the 2024 Golden I Awards
01/08/202421:30PR Newswire (US)Scripps promotes Detroit station sales leader to VP and general manager of KTNV in Las VegasNASDAQ:SSPEW Scripps Company
01/08/202421:30PR Newswire (US)Uranium Royalty Corp. Completes Acquisition of Additional Royalty on the Churchrock Uranium Project, New Mexico, USATSX:URCUranium Royalty Corp
01/08/202421:30PR Newswire (US)ONEOK Issues Annual Corporate Sustainability ReportNYSE:OKEONEOK Inc
01/08/202421:30PR Newswire (US)Servotronics Announces Death of Board Member Edward C. CosgroveAMEX:SVTServotronics Inc
01/08/202421:30PR Newswire (US)Uranium Royalty Corp. Completes Acquisition of Additional Royalty on the Churchrock Uranium Project, New Mexico, USANASDAQ:UROYUranium Royalty Corporation
01/08/202421:30PR Newswire (US)Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2024 and Cash DividendNYSE:SEMSelect Medical Holdings Corporation

Your Recent History

BOV
C2RS34
CRISPR Therapeutics
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved